| Therapeutic inhibition of the receptor tyrosine kinase AXL improves sensitivity to platinum and taxane in ovarian cancer JM Quinn, MM Greenwade, ML Palisoul, G Opara, K Massad, L Guo, ... Molecular cancer therapeutics 18 (2), 389-398, 2019 | 43 | 2019 |
| Inhibition of the receptor tyrosine kinase AXL restores paclitaxel chemosensitivity in uterine serous cancer ML Palisoul, JM Quinn, E Schepers, IS Hagemann, L Guo, K Reger, ... Molecular cancer therapeutics 16 (12), 2881-2891, 2017 | 29 | 2017 |
| p5RHH nanoparticle-mediated delivery of AXL siRNA inhibits metastasis of ovarian and uterine cancer cells in mouse xenografts KA Mills, JM Quinn, ST Roach, M Palisoul, M Nguyen, H Noia, L Guo, ... Scientific reports 9 (1), 4762, 2019 | 22 | 2019 |
| Uncovering protein–protein interactions through a team-based undergraduate biochemistry course DL Cookmeyer, ES Winesett, B Kokona, AR Huff, S Aliev, NB Bloch, ... PLoS Biology 15 (11), e2003145, 2017 | 14 | 2017 |
| The impact of underrepresented minority or marginalized identity status on training outcomes of MD-PhD students MA Torres Acosta, S Chandra, S Li, E Yoon, D Selgrade, J Quinn, ... BMC Medical Education 23 (1), 1-11, 2023 | 10 | 2023 |
| SQ1274, a novel microtubule inhibitor, inhibits ovarian and uterine cancer cell growth KA Mills, ST Roach, JM Quinn, L Guo, HM Beck, E Lomonosova, ... Gynecologic oncology 151 (2), 337-344, 2018 | 5 | 2018 |
| Aggregation Profiling of C9orf72 Dipeptide Repeat Proteins Transgenically Expressed in Drosophila melanogaster Using an Analytical Ultracentrifuge Equipped … B Kokona, NR Cunningham, JM Quinn, R Fairman Protein Self-Assembly: Methods and Protocols, 81-90, 2019 | 3 | 2019 |
| Size Analysis of C9orf72 Dipeptide Repeat Proteins Expressed in Drosophila melanogaster Using Semidenaturing Detergent Agarose Gel Electrophoresis NR Cunningham, B Kokona, JM Quinn, R Fairman Protein Self-Assembly: Methods and Protocols, 91-101, 2019 | 2 | 2019 |
| Multiple Bacteriophage Selection Strategies for Improved Affinity of a Peptide Targeting ERBB2 BM Larimer, JM Quinn, K Kramer, A Komissarov, SL Deutscher International journal of peptide research and therapeutics 21, 383-392, 2015 | 2 | 2015 |
| A novel nanoparticle platform, p5RHH-siAXL, inhibits metastasis in gynecologic serous cancers KA Mills, JM Quinn, ST Roach, M Palisoul, AR Hagemann, PH Thaker, ... Gynecologic Oncology 149, 69-70, 2018 | 1 | 2018 |
| Tumor and stromal AXL expression regulate ovarian cancer metastasis MM Mullen, LN Van Biljon, J Quinn, M Greenwade, G Opara, H Noia, ... Cancer Research 82 (12_Supplement), 2429-2429, 2022 | | 2022 |
| Tumor vs stroma: Understanding the Role of Discoidin Domain Receptor 2 (DDR2) in ovarian cancer metastasis, chemoresistance, and survival (Final version-please disregard first … MM Greenwade, HB Noia, JM Quinn, G Opara, D Wilke, L Guo, ... Gynecologic Oncology 154 (1), e27-e28, 2019 | | 2019 |
| AXL in metastatic ovarian cancer tumors is a targetable biomarker associated with chemoresistance and poor prognosis MM Mullen, JM Quinn, M Greenwade, G Opara, H Beck-Noia, ... Gynecologic Oncology 154, 79-80, 2019 | | 2019 |
| Inhibition of AXL improves response to platinum and taxane in chemotherapy-resistant uterine and ovarian cancers J Quinn, M Palisoul, L Guo, A Hagemann, M Powell, D Mutch, C McCourt, ... Cancer Research 78 (13_Supplement), 4034-4034, 2018 | | 2018 |
| Treatment with SQ1274, a novel tubulin polymerization inhibitor, results in improved therapeutic efficacy compared to paclitaxel in serous gynecologic cancers KA Mills, ST Roach, JM Quinn, CM Starks, AR Ilivicky, AR Hagemann, ... Gynecologic Oncology 149, 181, 2018 | | 2018 |
| AXL inhibition improves chemoresponse in gynecologic serous cancers JM Quinn, M Palisoul, K Massad, M Greenwade, AR Hagemann, ... Gynecologic Oncology 149, 47, 2018 | | 2018 |
| AXL Inhibition Improves Chemo Response in Gynecologic Serous Cancers. K Fuh, J Quinn, M Palisoul, M Greenwade, K Massad, L Guo, ... REPRODUCTIVE SCIENCES 25, 91A-92A, 2018 | | 2018 |
| Treatment with SQ1274, a Novel Tubulin Polymerization Inhibitor, Results in Improved Therapeutic Efficacy Compared to Paclitaxel in Serous Gynecologic Cancers KA Mills, JM Quinn, HM Noia, L Guo, GR Eldridge, DG Mutch, C Starks, ... Gynecologic Oncology 147 (1), 200-201, 2017 | | 2017 |
| Inhibition of the Receptor Tyrosine Kinase AXL Sensitizes Uterine Serous Cancer to Paclitaxel via Increased Accumulation of Paclitaxel in Tumor Cells J Quinn, M Palisoul, L Guo, K Fuh Gynecologic Oncology 147 (1), 200, 2017 | | 2017 |
| P5RHH-siAXL nanoparticle is a novel targeted therapy in metastatic gynecologic serous cancers KA Mills, M Palisoul, JM Quinn, AR Hagemann, PH Thaker, MA Powell, ... Gynecologic Oncology 145, 118, 2017 | | 2017 |
